The CDC said Friday, Nov. 20, that seasonal flu activity continues to increase nationally, and that many surveillance indicators are higher than is typical for this point in the year. That earlier rise, the agency cautioned, does not necessarily mean a higher peak or a more severe season overall.

In its FluView report for Week 45, the week ending Nov. 14, public health laboratories reported 613 influenza viruses, including 608 influenza A and 5 influenza B. Of the 365 influenza A viruses that were subtyped, 352, or 96.4 percent, were influenza A(H1N1)pdm09, 12, or 3.3 percent, were A(H3N2), and 1, or 0.3 percent, was A(H5). Since Week 21, which ended May 30, 84.8 percent of reported influenza A viruses have been A(H1N1)pdm09. CDC said those are still the H1N1 viruses that emerged in 2009, and that it is too early to say which viruses may predominate or whether there are implications for vaccine effectiveness. So far, almost all of the influenza viruses collected and antigenically characterized in the United States since Week 21 have been antigenically similar to their vaccine reference viruses in CDC laboratory assays.

The preliminary in-season severity assessment still classifies flu activity as low across all ages. CDC estimates at least 3.7 million illnesses, 50,000 hospitalizations, and 2,800 deaths associated with flu so far this season. Two pediatric flu deaths were reported this week, bringing the season total to seven; those counts are preliminary and can rise because investigations take time. FluSight forecasts a likely national increase in flu hospital admissions and in the share of emergency department visits due to flu for the week ending Dec. 5, with new admissions forecast between 9,200 and 36,100 and the national ED share between 1.7 percent and 7.6 percent.

A separate CDC respiratory-illness page, also updated Friday, said the amount of acute respiratory illness sending people to health care is low but increasing. COVID-19 activity is low nationally. RSV activity is low in most of the country. Rhinovirus and enterovirus are elevated nationally but declining, and respiratory adenovirus is elevated and increasing in some regions. CDC expects the 2026-2027 respiratory season to be much like last season, with a similar number of peak hospitalizations from COVID-19, flu, and RSV unless that outlook is updated.

Annual flu vaccination is recommended, the FluView report said, and vaccines are available for people 6 months and older. Anyone who is recommended to get a flu shot and has not gotten one yet this season is encouraged to be vaccinated now. Because of Thanksgiving, the Week 46 FluView will be posted on Nov. 30. All of this week's figures are preliminary and may change as more reports come in.